MedTrace Logo

Tubal Flushing Using Water Soluble Media for Unexplained Infertility

NCT02433418 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-01-23

No results posted yet for this study

Summary

300 women with unexplained infertility will be randomly divided into 2 equal groups: Group 1 will be offered tubal flushing with water soluble media through hysterosalpingography (HSG) and group 2 will receive no intervention

Conditions

Interventions

PROCEDURE

Tubal flushing by Urografin®

Women will have tubal flushing through HSG using water soluble media (Urographin ®)

DRUG

Diclofenac

Women will receive oral diclofenac 50 mg (voltaren ®) 1 hour before hysterosalpingography

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02433418 on ClinicalTrials.gov